234 related articles for article (PubMed ID: 7673699)
1. Human antibody response in human peripheral blood leukocyte/severe combined immunodeficient chimeric model is dependent on B and T cell costimulation via CD40/CD40 ligand.
Chen FA; Williams SS; Fanslow WC; Bankert RB
J Immunol; 1995 Sep; 155(6):2833-40. PubMed ID: 7673699
[TBL] [Abstract][Full Text] [Related]
2. Cellular interaction in germinal centers. Roles of CD40 ligand and B7-2 in established germinal centers.
Han S; Hathcock K; Zheng B; Kepler TB; Hodes R; Kelsoe G
J Immunol; 1995 Jul; 155(2):556-67. PubMed ID: 7541819
[TBL] [Abstract][Full Text] [Related]
3. A model of human anti-T-cell monoclonal antibody therapy in SCID mice engrafted with human peripheral blood lymphocytes.
Tsuchida M; Brown SA; Tutt LM; Tan J; Seehafer DL; Harris JP; Xun CQ; Thompson JS
Clin Transplant; 1997 Oct; 11(5 Pt 2):522-8. PubMed ID: 9361954
[TBL] [Abstract][Full Text] [Related]
4. The regulation of T cell-dependent antibody formation in vitro by CD40 ligand and IL-2.
Grabstein KH; Maliszewski CR; Shanebeck K; Sato TA; Spriggs MK; Fanslow WC; Armitage RJ
J Immunol; 1993 Apr; 150(8 Pt 1):3141-7. PubMed ID: 7682232
[TBL] [Abstract][Full Text] [Related]
5. The role of CD40-CD40 ligand interactions in suppression of human B cell responsiveness by CD4+ T cells.
Hirohata S
Cell Immunol; 1997 Nov; 182(1):20-8. PubMed ID: 9427806
[TBL] [Abstract][Full Text] [Related]
6. CD40 and its ligand in the regulation of humoral immunity.
Klaus SJ; Berberich I; Shu G; Clark EA
Semin Immunol; 1994 Oct; 6(5):279-86. PubMed ID: 7532458
[TBL] [Abstract][Full Text] [Related]
7. CD40 ligand induction on T cell subsets by peptide-presenting B cells: implications for development of the primary T and B cell response.
Jaiswal AI; Croft M
J Immunol; 1997 Sep; 159(5):2282-91. PubMed ID: 9278317
[TBL] [Abstract][Full Text] [Related]
8. Engraftment of human peripheral blood leukocytes into severe combined immunodeficient mice results in the long term and dynamic production of human xenoreactive antibodies.
Williams SS; Umemoto T; Kida H; Repasky EA; Bankert RB
J Immunol; 1992 Oct; 149(8):2830-6. PubMed ID: 1401915
[TBL] [Abstract][Full Text] [Related]
9. CD40 ligand-independent B cell activation revealed by CD40 ligand-deficient T cell clones: evidence for distinct activation requirements for antibody formation and B cell proliferation.
Lane P; Burdet C; McConnell F; Lanzavecchia A; Padovan E
Eur J Immunol; 1995 Jun; 25(6):1788-93. PubMed ID: 7615009
[TBL] [Abstract][Full Text] [Related]
10. Blockade of CD40/CD40 ligand interactions prevents induction of factor VIII inhibitors in hemophilic mice but does not induce lasting immune tolerance.
Reipert BM; Sasgary M; Ahmad RU; Auer W; Turecek PL; Schwarz HP
Thromb Haemost; 2001 Dec; 86(6):1345-52. PubMed ID: 11776297
[TBL] [Abstract][Full Text] [Related]
11. CD40-mediated stimulation contributes to lymphocyte proliferation, antibody production, eosinophilia, and mastocytosis during an in vivo type 2 response, but is not required for T cell IL-4 production.
Lu P; Urban JF; Zhou XD; Chen SJ; Madden K; Moorman M; Nguyen H; Morris SC; Finkelman FD; Gause WC
J Immunol; 1996 May; 156(9):3327-33. PubMed ID: 8617957
[TBL] [Abstract][Full Text] [Related]
12. B cells regulate CD40 ligand-induced IL-12 production in antigen-presenting cells (APC) during T cell/APC interactions.
Maruo S; Oh-hora M; Ahn HJ; Ono S; Wysocka M; Kaneko Y; Yagita H; Okumura K; Kikutani H; Kishimoto T; Kobayashi M; Hamaoka T; Trinchieri G; Fujiwara H
J Immunol; 1997 Jan; 158(1):120-6. PubMed ID: 8977182
[TBL] [Abstract][Full Text] [Related]
13. CD40 ligand-CD40 interaction in Ig isotype switching in mature and immature human B cells.
Aversa G; Punnonen J; Carballido JM; Cocks BG; de Vries JE
Semin Immunol; 1994 Oct; 6(5):295-301. PubMed ID: 7532459
[TBL] [Abstract][Full Text] [Related]
14. Growth-inhibitory effects of CD40 ligand (CD154) and its endogenous expression in human breast cancer.
Tong AW; Papayoti MH; Netto G; Armstrong DT; Ordonez G; Lawson JM; Stone MJ
Clin Cancer Res; 2001 Mar; 7(3):691-703. PubMed ID: 11297266
[TBL] [Abstract][Full Text] [Related]
15. CD40 ligand is required for resolution of Pneumocystis carinii pneumonia in mice.
Wiley JA; Harmsen AG
J Immunol; 1995 Oct; 155(7):3525-9. PubMed ID: 7561048
[TBL] [Abstract][Full Text] [Related]
16. CD40 ligand-CD40 interactions are necessary for the initiation of insulitis and diabetes in nonobese diabetic mice.
Balasa B; Krahl T; Patstone G; Lee J; Tisch R; McDevitt HO; Sarvetnick N
J Immunol; 1997 Nov; 159(9):4620-7. PubMed ID: 9379064
[TBL] [Abstract][Full Text] [Related]
17. NOD/SCID mice engrafted with human peripheral blood lymphocytes can be a model for investigating B cells responding to blood group A carbohydrate determinant.
Zhou W; Ohdan H; Tanaka Y; Hara H; Tokita D; Onoe T; Asahara T
Transpl Immunol; 2003; 12(1):9-18. PubMed ID: 14551028
[TBL] [Abstract][Full Text] [Related]
18. Human rheumatoid factor production is dependent on CD40 signaling and autoantigen.
Kyburz D; Corr M; Brinson DC; Von Damm A; Tighe H; Carson DA
J Immunol; 1999 Sep; 163(6):3116-22. PubMed ID: 10477577
[TBL] [Abstract][Full Text] [Related]
19. Antibody to gp39, the ligand for CD40 significantly inhibits the humoral response from Graves' thyroid tissues xenografted into severe combined immunodeficient (SCID) mice.
Resetkova E; Kawai K; Enomoto T; Arreaza G; Togun R; Foy TM; Noelle RJ; Volpé R
Thyroid; 1996 Aug; 6(4):267-73. PubMed ID: 8875745
[TBL] [Abstract][Full Text] [Related]
20. Blockade of CD40 ligand-CD40 interaction impairs CD4+ T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation.
Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Buhlman J; Xu J; Flavell RA; Korngold R; Noelle R; Vallera DA
J Immunol; 1997 Jan; 158(1):29-39. PubMed ID: 8977172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
